Further investigations on the significance of a plasma coagulation-accelerating factor in glomerular disease

Area of Science:

• Nephrology
• Hematology
• Clinical Pathology

Background:

• Renal disease, particularly glomerulonephritis, can involve complex pathophysiological mechanisms.
• Coagulation abnormalities may play a role in the development and progression of kidney diseases.

Purpose of the Study:

• To investigate the prevalence of coagulation acceleration factor (CAF) in patients with renal disease.
• To explore the relationship between CAF, activated partial thromboplastin time, F.VIII:C/vWf, prekallikrein, plasminogen, and glomerulonephritis pathogenesis.

Main Methods:

• Study included 117 patients admitted for renal biopsy.
• Assessed prevalence of CAF and plasma prekallikrein levels.
• Correlated findings with glomerulonephritis type, activity, and progression.

Main Results:

• Thirteen percent of patients exhibited evidence of CAF.
• Fifteen percent of patients had reduced plasma prekallikrein levels.
• No significant correlation was observed between measured variables and glomerular disease parameters.

Conclusions:

• The prevalence of CAF and reduced prekallikrein in renal disease patients was established.
• No direct relationship was found between these coagulation factors and the pathogenesis or progression of glomerulonephritis in the study cohort.